Then, the signal cascades and finishes in interferon regulatory factor 3 (IRF3) and NF-κB targets in the nucleus, leading to the secretion of type-I interferon, which is vital to tumor-specific T cells [103,104]. The gene discussed is IRF3; the disease is neoplasm.